Literature DB >> 10415766

Targeting matrix metalloproteinases in human prostate cancer.

Q A Sang1, M A Schwartz, H Li, L W Chung, H E Zhau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10415766     DOI： 10.1111/j.1749-6632.1999.tb07720.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.

Authors:  Yonghao Jin; Mark D Roycik; Dale B Bosco; Qiang Cao; Manuel H Constantino; Martin A Schwartz; Qing-Xiang Amy Sang
Journal:  J Med Chem       Date:  2013-05-16       Impact factor: 7.446

2.  A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis.

Authors:  Dale B Bosco; Mark D Roycik; Yonghao Jin; Martin A Schwartz; Ty J Lively; Diego A R Zorio; Qing-Xiang Amy Sang
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.